RAPT Therapeutics Slips 9% After Pricing Public Offering

On:

Shares of RAPT Therapeutics, Inc. (RAPT) are down more than 9% Friday morning at $19.26.

The company today priced its public offering of 4,054,055 shares at $18.50 per share.

Gross proceeds of $75 million is estimated from the offering, which is expected to close on November 22.

RAPT has traded in the range of $9.85- $40.74 in the last 1 year.

Source: Read Full Article

Lates News:
  1. $BTC: Five Reasons Why Bitcoin Could Be a Better Store of Value Than Gold
  2. Pundit Who Predicted Bitcoin's Plunge To $20k Lowers Bet To $12,000
  3. $BTC: Anthony Pompliano Says ‘In Our Darkest Moment, Bitcoin Steps to the Forefront’
  4. KuCoin To Suspend Mining Pool Services Starting August 15
  5. NuScale Power Rallies After Standard Power Selecting Its SMR Technology